Press Release

/Press Release
Press Release 2017-12-27T12:27:22+00:00

Jewish New Year fruit may hold seeds of hope for brain disease sufferers

By | December 25th, 2017|Categories: Blog|

 Israeli neurologist, nanotech expert make pomegranate oil capsules that send antioxidants where they can have the most effect By SHOSHANNA SOLOMON | 18 September 2017, 4:36 pm Pomegranates at the Mahane Yehuda market in Jerusalem on August [...]

Comments Off on Jewish New Year fruit may hold seeds of hope for brain disease sufferers

BiomX Acquires RondinX to Boost Microbiome Discovery and Development Capabilities

By | December 21st, 2017|Categories: Blog|

Acquisition expands BiomX's pipeline with novel microbial targets for treating liver diseases. In parallel, 8VC, an angel investor in RondinX, to invest in BiomX  NEWS PROVIDED BY | Biomx Ltd | Dec 19, 2017, 07:30 ET NESS ZIONA, Israel, Dec. 19, [...]

Comments Off on BiomX Acquires RondinX to Boost Microbiome Discovery and Development Capabilities

Future of the #Cancer #Treatments

By | December 7th, 2017|Categories: Blog|

Ayala #Pharmaceuticals, Founded by Israel Biotech Fund, aMoon and Harel Insurance, Enters Exclusive Worldwide License Agreement with Bristol-Myers Squibb (BMS) to Develop Cancer #Treatments December 06, 2017 09:30 AM Eastern Standard Time REHOVOT, Israel--(BUSINESS WIRE)--Ayala [...]

Comments Off on Future of the #Cancer #Treatments

UK company wins global #medicine #award for its ground-breaking potential MS #treatment

By | December 6th, 2017|Categories: Blog|

NOVEMBER 07, 2017 A leading scientist battling to halt the development of Multiple Sclerosis has revealed that clinical human trials will start by 2020, after her company was honoured with a major nano medicine award. Dr Su [...]

Comments Off on UK company wins global #medicine #award for its ground-breaking potential MS #treatment

Atox Bio closes $30M round as it speeds through late-stage trials

By | December 5th, 2017|Categories: Blog|

by brittany meiling — on December 4, 2017 09:06 AM EST Israel’s Atox Bio has raised $30 million — the latest in a long line of equity deals — to help push its #immune #modulators through late-stage clinical trials. The company [...]

Comments Off on Atox Bio closes $30M round as it speeds through late-stage trials